| Anakinra treatment in critically ill COVID-19 patients: a prospective cohort study EJ Kooistra, NJB Waalders, I Grondman, NAF Janssen, AH de Nooijer, ... Critical care 24 (1), 688, 2020 | 129 | 2020 |
| Increased plasma heparanase activity in COVID-19 patients B Buijsers, C Yanginlar, A de Nooijer, I Grondman, ML Maciej-Hulme, ... Frontiers in immunology 11, 575047, 2020 | 127 | 2020 |
| Complement activation in the disease course of coronavirus disease 2019 and its effects on clinical outcomes AH de Nooijer, I Grondman, NAF Janssen, MG Netea, L Willems, ... The Journal of infectious diseases 223 (2), 214-224, 2021 | 106 | 2021 |
| Impaired ketogenesis ties metabolism to T cell dysfunction in COVID-19 F Karagiannis, K Peukert, L Surace, M Michla, F Nikolka, M Fox, P Weiss, ... Nature 609 (7928), 801-807, 2022 | 88 | 2022 |
| Outcomes associated with use of a kinin B2 receptor antagonist among patients with COVID-19 FL van de Veerdonk, IJE Kouijzer, AH de Nooijer, HG van der Hoeven, ... JAMA network open 3 (8), e2017708-e2017708, 2020 | 77 | 2020 |
| Dysregulated innate and adaptive immune responses discriminate disease severity in COVID-19 NAF Janssen, I Grondman, AH de Nooijer, CK Boahen, VACM Koeken, ... The Journal of infectious diseases 223 (8), 1322-1333, 2021 | 71 | 2021 |
| A higher BMI is not associated with a different immune response and disease course in critically ill COVID-19 patients EJ Kooistra, AH de Nooijer, WJ Claassen, I Grondman, NAF Janssen, ... International Journal of Obesity 45 (3), 687-694, 2021 | 54 | 2021 |
| Health-related quality of life and mental health in primary aldosteronism: a systematic review MS Velema, AH de Nooijer, VWG Burgers, ARMM Hermus, ... Hormone and Metabolic Research 49 (12), 943-950, 2017 | 39 | 2017 |
| Development and validation of SCOPE score: A clinical score to predict COVID-19 pneumonia progression to severe respiratory failure EJ Giamarellos-Bourboulis, G Poulakou, A de Nooijer, H Milionis, ... Cell Reports Medicine 3 (3), 2022 | 29 | 2022 |
| Increased sTREM-1 plasma concentrations are associated with poor clinical outcomes in patients with COVID-19 AH de Nooijer, I Grondman, S Lambden, EJ Kooistra, NAF Janssen, ... Bioscience Reports 41 (7), BSR20210940, 2021 | 27 | 2021 |
| ImmunoSep (Personalised Immunotherapy in Sepsis) international double-blind, double-dummy, placebo-controlled randomised clinical trial: study protocol A Kotsaki, P Pickkers, M Bauer, T Calandra, M Lupse, WJ Wiersinga, ... BMJ open 12 (12), e067251, 2022 | 21 | 2022 |
| Pitfalls in complement analysis: A systematic literature review of assessing complement activation RJ Brandwijk, MAHM Michels, M van Rossum, AH de Nooijer, PH Nilsson, ... Frontiers in immunology 13, 1007102, 2022 | 21 | 2022 |
| The association of TSH and thyroid hormones with lymphopenia in bacterial sepsis and COVID-19 I Grondman, AH de Nooijer, N Antonakos, NAF Janssen, M Mouktaroudi, ... The Journal of Clinical Endocrinology & Metabolism 106 (7), 1994-2009, 2021 | 20 | 2021 |
| Targeted proteomics identifies circulating biomarkers associated with active COVID-19 and post-COVID-19 M Zoodsma, AH de Nooijer, I Grondman, MK Gupta, A Bonifacius, ... Frontiers in immunology 13, 1027122, 2022 | 19 | 2022 |
| A systems approach to inflammation identifies therapeutic targets in SARS-CoV-2 infection FL van de Veerdonk, NAF Janssen, I Grondman, AH de Nooijer, ... medRxiv, 2020.05. 23.20110916, 2020 | 19 | 2020 |
| Adipocytokine plasma concentrations reflect influence of inflammation but not body mass index (BMI) on clinical outcomes of COVID‐19 patients: a prospective observational study … AH de Nooijer, EJ Kooistra, I Grondman, NAF Janssen, LAB Joosten, ... Clinical Obesity 13 (2), e12568, 2023 | 17 | 2023 |
| Complement activation in severely ill patients with sepsis: no relationship with inflammation and disease severity AH de Nooijer, A Kotsaki, E Kranidioti, M Kox, P Pickkers, EJM Toonen, ... Critical Care 27 (1), 63, 2023 | 14 | 2023 |
| Joosten LAB, Nijenhuis T, Netea MG, Hilbrands L, van de Veerdonk FL, Duivenvoorden R, de Mast Q and van der Vlag J (2020) Increased Plasma Heparanase Activity in COVID-19 Patients B Buijsers, C Yanginlar, A de Nooijer, I Grondman, ML Maciej-Hulme, ... Front. Immunol. 11: 575047. doi: 10.3389, 2020 | 14 | 2020 |
| A disease-specific Quality of Life questionnaire for primary aldosteronism MS Velema, A de Nooijer, ARMM Hermus, HJLM Timmers, JWM Lenders, ... Endocrine connections 8 (4), 389-397, 2019 | 11 | 2019 |
| LAB Joosten, MM van den Heuvel, J. Hoogerwerf, Q. de Mast, P. Pickkers, MG Netea, and FL van de Veerdonk. 2021. Dysregulated innate and adaptive immune responses discriminate … NAF Janssen, I Grondman, AH de Nooijer, CK Boahen, V Koeken, ... J Infect Dis 223 (8), 1322-1333, 0 | 11 | |
